Basal Cell Carcinoma (BCC) | Medibuddy
9th July 2023

Basal Cell Carcinoma (BCC)

The most common form of skin cancer which generally has a good prognosis due to its slow local invasion and infrequent metastasis. Risk factors include prolonged and cumulative UV exposure on sun-exposed sites, fair skin, and previous solar damage such as AKs. Biopsy confirms the histological subtype and informs management. Nodular BCC is the most common. Most BCCs are treated surgically, such as by excision, Mohs micrographic surgery (lesions that are high risk, recurrent or if sited on areas of cosmetic concern), curettage and cautery, and cryotherapy. Non-surgical treatments include topical creams such as 5-FU (cytotoxic agent) and Imiquimod (immunomodulating agent), PDT and radiotherapy.

Type Description Treatment
Nodular Pearly pink nodule

Overlying telangiectasia

May develop central necrosis – “rodent ulcer”

Excisional surgery

Mohs surgery

Superficial Erythematous macule/patch/plaque Topical creams

PDT

Cryosurgery

Curettage and cautery

Excisional surgery

Morpheaform/infiltrative Waxy plaque

Scar like appearance

Mohs surgery

Table 1: Three different types of BCCs with associated descriptions and treatment options.

MRCP Part 1 - Nodular BCC

Nodular BCC with overlying telangiectasia sited on the nasolabial fold.

Image Source: Wikimedia Commons (2017). Basal-cell Carcinoma, Licensed under a creative commons licence. Available for free at: https://commons.wikimedia.org/wiki/File:Basal-cell_Carcinoma.jpg (Accessed on: 3 November 2021).

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.